April 8, 2026
Decoding and Targeting Epileptic Brain States with Ritchie Chen, PhD
Temporal lobe epilepsy (TLE) is among the most common neurological disorders, yet about 30% of patients do not respond to existing medications and continue to experience seizures. To advance new therapies, I will present our recent work developing engineered phenotyping platforms for biomarker discovery in mouse models of TLE.